@article{ref1,
title="Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions",
journal="Psychiatry and the Clinical Neurosciences",
year="2007",
author="Nagata, Tomoyuki and Harada, Daisuke and Aoki, Kimiyoshi and Kada, Hirohide and Miyata, Hisatsugu and Kasahara, Hiroo and Nakayama, Kazuhiko",
volume="61",
number="6",
pages="695-697",
abstract="Anticonvulsants have been used for the treatment of impulsive aggression since the 1980s. A 50-year-old man suffered from irritability and agitation after developing a right ipsilateral frontal lobe infarction as a result of Moyamoya disease; these symptoms caused difficulties with his working and interpersonal relationships. The patient had been treated using multiple benzodiazepine agents for 2 years but his symptoms had not improved. However, after treatment with carbamazepine (CBZ; 200 mg) was begun, the patient's irritability and agitation gradually decreased. The efficacy of CBZ treatment in this patient suggests a method for controlling benzodiazepine-resistant impulsive aggression.<p /><p>Language: en</p>",
language="en",
issn="1323-1316",
doi="10.1111/j.1440-1819.2007.01737.x",
url="http://dx.doi.org/10.1111/j.1440-1819.2007.01737.x"
}